Drägerwerk KGaA Valuation

Is 000330446 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 000330446 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 000330446 (CHF59.5) is trading below our estimate of fair value (CHF173.98)

Significantly Below Fair Value: 000330446 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 000330446?

Key metric: As 000330446 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 000330446. This is calculated by dividing 000330446's market cap by their current earnings.
What is 000330446's PE Ratio?
PE Ratio	7.2x
Earnings	€113.44m
Market Cap	€792.54m

000330446 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.3x
Enterprise Value/EBITDA	4x
PEG Ratio	3.6x

Price to Earnings Ratio vs Peers

How does 000330446's PE Ratio compare to its peers?

The above table shows the PE ratio for 000330446 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	68.9x
MED Medartis Holding	194.2x	53.9%	CHF 783.1m
METN Metall Zug	7.4x	-29.6%	CHF 504.0m
MOVE Medacta Group	42.2x	18.4%	CHF 2.2b
SOON Sonova Holding	31.8x	11.2%	CHF 17.9b
000330446 Drägerwerk KGaA	7.2x	2.0%	CHF 792.5m

Price-To-Earnings vs Peers: 000330446 is good value based on its Price-To-Earnings Ratio (7.2x) compared to the peer average (68.9x).

Price to Earnings Ratio vs Industry

How does 000330446's PE Ratio compare vs other companies in the European Medical Equipment Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 000330446 is good value based on its Price-To-Earnings Ratio (7.2x) compared to the European Medical Equipment industry average (29.6x).

Price to Earnings Ratio vs Fair Ratio

What is 000330446's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

000330446 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	7.2x
Fair PE Ratio	16.7x

Price-To-Earnings vs Fair Ratio: 000330446 is good value based on its Price-To-Earnings Ratio (7.2x) compared to the estimated Fair Price-To-Earnings Ratio (16.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Sonova Holding

CHF 17.9b

Manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

SOON

CHF 301.00

-1.0%

19.3%

Galenica

CHF 3.8b

Operates as a healthcare service provider in Switzerland and internationally.

GALE

CHF 76.70

1.1%

5.6%

CVS Health

US$75.5b

Provides health solutions in the United States.

CVS

US$47.40

n/a